Finance ForgeBETA
Crear cuenta gratis
1)Empresas2)Rankings3)Iniciar sesión
Finance Forge Terminal v1.51.3
PrivacidadTérminosCookiesAviso Legal
● Connected
SRTS US Equity
Sensus Healthcare, Inc.
2.89USD▼ 1.37%
Healthcare
Medical Devices
96)Comparar97)Tesis →
Market Cap
$48M
Shares Outstanding
16M
Revenue (TTM)
$18M
Net Income (TTM)
−$15M
FCF (TTM)
−$7M
— Annual —FY2025
Revenue
$27M
Gross Margin
43.2%
Operating Margin
-37.5%
Net Margin
-28.1%
FCF Margin
1.2%
ROE
-16.1%
ROCE
-21.3%
Current Ratio
9.72
FCF / Share
0.02
Book Value / Share
2.92
SRTS US Equity
2.89USD▼ 1.37%
Tesis →

Sensus Healthcare, Inc. (SRTS): análisis fundamental y valoración

Sensus Healthcare, Inc. cotiza a 2.89 USD y tiene una capitalización bursátil de $48M. En los últimos 12 meses ha facturado $18M con un margen de flujo de caja libre del 1.2%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud

Price History
Loading...
Perfil
BolsaNasdaqPaísUnited StatesEmpleados60Beta1.19Web↗ sensushealthcare.com

Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superfic…

Múltiplos de Valoración
P/E (Annual)
—
P/E (TTM)
—
P/FCF (Annual)
143.3×
P/FCF (TTM)
—
EV/EBITDA
—
EV/Revenue
—
P/Sales
1.7×
P/Book
1.0×
Rentabilidad (Último Anual)
Gross Margin
43.2%
Operating Margin
-37.5%
Net Margin
-28.1%
FCF Margin
1.2%
ROE
-16.1%
ROCE
-21.3%
ROA
-14.6%
Effective Tax Rate
19.8%
Métricas TTM
Revenue TTM
$18M
Gross Profit TTM
$6M
Operating Income TTM
−$13M
Net Income TTM
−$15M
FCF TTM
−$7M
EPS TTM
-0.94
Quarters Used
4
TTM Period
2025-09-30 → 2026-06-30
Solidez del Balance
Net Debt
—
Net Debt / EBITDA
—
Debt / Equity
—
Current Ratio
9.72
Interest Coverage
—
Working Capital
$41M
Book Value / Share
2.92
Net Debt / Share
—
Crecimiento (YoY)
Revenue YoY
-34.3%
Net Income YoY
-216.1%
FCF YoY
+130.0%
EPS Diluted YoY
-214.6%
Retorno al Accionista
Dividend Yield
—
Payout Ratio
—
FCF / Share
0.02
CapEx % Revenue
0.7%
Rev / Employee
458,033
Próximos Eventos
Historial EPS
Periodo2026-082026-052026-022025-11
Real—$-0.16$-0.19$-0.06
Estimado$-0.11$-0.11$-0.05$-0.11
Sorpresa—-45.5%-280.0%+45.5%
Empresas similares
Smart Money
vs Sector: Healthcare (1130 empresas)
MétricaSRTSMediana SectorΔ
Gross Margin43.2%57.0%-13.9%
Operating Margin-37.5%-38.6%+1.1%
Net Margin-28.1%-33.6%+5.5%
FCF Margin1.2%-13.9%+15.1%
ROE-16.1%-40.4%+24.3%
ROA-14.6%-32.0%+17.5%
Current Ratio9.722.84+6.88
Debt / Equity—0.28—
Scoring Fundamental
Piotroski F-Score
4/ 8Moderado
✗F1ROA positivo (rentabilidad activos)
✓F2Flujo caja operativo positivo
✗F3ROA mejora vs año anterior
✓F4Calidad de beneficios (OCF > ROA)
✗F5Apalancamiento baja
✓F6Liquidez mejora (current ratio)
✓F7Sin dilución accionarial
✗F8Margen bruto mejora
✗F9Rotación activos mejora
Altman Z-ScoreZona Segura
6.74
x1_working_capital0.776
x2_retained_earnings0.108
x3_ebit-0.194
x4_market_equity9.629
x5_sales0.518
>2.99 segura · 1.81–2.99 gris · <1.81 riesgo
Capital Allocation
3/ 8Débil
✓FCF+Free cash flow positivo
✗FCFmMargen FCF > 10%
✓DilucSin dilución significativa (< 2%/año en 3 años)
✗Rev↑Revenue CAGR 3 años > 5%
✗ROCERetorno sobre capital empleado > 10%
✗DeudaDeuda neta/EBITDA < 3× (o posición de caja neta)
✗Mg↑Margen operativo ≥ hace 2-3 años (tolerancia -2pp)
✓Inv.R&D + Capex > 3% de revenue (reinversión en el negocio)
Histórico Piotroski F-Score
Histórico de Múltiplos